ABL-specific tyrosine kinase inhibitor imatinib as salvage therapy in a child with Philadelphia chromosome-positive acute mixed lineage leukemia (AMLL)

被引：0

作者：

B Selle

C Bär

S Hecker

U Schmidt-Rohr

S Viehmann

K-M Debatin

D Reinhardt

机构：

[1] University of Heidelberg,Department of Pediatric Oncology and Hematology

[2] University of Giessen,Department of Pediatric Oncology and Hematology

[3] University of Ulm,Department of Pediatric Oncology and Hematology

[4] University of Münster,Department of Pediatric Oncology and Hematology

来源：

Leukemia | 2002年 / 16卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1393 / 1395

页数：2

共 50 条

[31] A de novo Philadelphia chromosome-positive acute mixed-lineage leukemia with both major and minor BCR/ABL mRNA transcripts
Tarumoto, T
Imagawa, S
Ohmine, K
Mano, A
Nagai, T
Takatoku, M
Muroi, K
Hatake, K
Ozawa, K
AMERICAN JOURNAL OF HEMATOLOGY, 2000, 65 (01) : 72 - 74
[32] Combination of venetoclax with BCR-ABL tyrosine kinase inhibitor as a therapeutic strategy for Philadelphia chromosome-positive leukemias
Zou, Jing-Ying
Huang, Si-Man
Zhoub, Hai-Xia
Xu, Ming-Zhu
Sun, Ai-Ning
Wu, De-Pei
Xue, Sheng-Li
Zhang, Tong-Tong
HEMATOLOGY, 2023, 28 (01)
[33] ABL kinase mutation and relapse in 4 pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia cases
Michinori Aoe
Akira Shimada
Michiko Muraoka
Kana Washio
Yoshimi Nakamura
Takahide Takahashi
Masahide Imada
Toshiyuki Watanabe
Ken Okada
Ritsuo Nishiuchi
Takako Miyamura
Kosuke Chayama
Misako Shibakura
Megumi Oda
Tsuneo Morishima
International Journal of Hematology, 2014, 99 : 609 - 615
[34] ABL kinase mutation and relapse in 4 pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia cases
Aoe, Michinori
Shimada, Akira
Muraoka, Michiko
Washio, Kana
Nakamura, Yoshimi
Takahashi, Takahide
Imada, Masahide
Watanabe, Toshiyuki
Okada, Ken
Nishiuchi, Ritsuo
Miyamura, Takako
Chayama, Kosuke
Shibakura, Misako
Oda, Megumi
Morishima, Tsuneo
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (05) : 609 - 615
[35] Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib in combination with chemotherapy
Ohno R.
Current Hematologic Malignancy Reports, 2006, 1 (3) : 180 - 187
[36] Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Jabbour, Elias
Kantarjian, Hagop M.
Aldoss, Ibrahim
Montesinos, Pau
Leonard, Jessica T.
Gomez-Almaguer, David
Baer, Maria R.
Gambacorti-Passerini, Carlo
McCloskey, James
Minami, Yosuke
Papayannidis, Cristina
Rocha, Vanderson
Rousselot, Philippe
Vachhani, Pankit
Wang, Eunice S.
Wang, Bingxia
Hennessy, Meliessa
Vorog, Alexander
Patel, Niti
Yeh, Tammie
Ribera, Jose-Maria
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (21): : 1814 - 1823
[37] Outcome of Patients with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) with Relapse After Tyrosine Kinase Inhibitor (TKI) Therapy
Lee, Hun Ju
O'Brien, Susan
Kantarjian, Hagop M.
Ravandi, Farhad
Faderl, Stefan
Koller, Charles
Konopleva, Marina
Verstovsek, Srdan
Kadia, Tapan
Garcia-Manero, Guillermo
Borthakur, Gautam
Wierda, William G.
Burger, Jan A.
Thomas, Deborah A.
Cortes, Jorge E.
BLOOD, 2011, 118 (21) : 659 - 659
[38] Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia
Assi, Rita
Kantarjian, Hagop
Short, Nicholas J.
Daver, Naval
Takahashi, Koichi
Garcia-Manero, Guillermo
DiNardo, Courtney
Burger, Jan
Cortes, Jorge
Jain, Nitin
Wierda, William
Chamoun, Salim
Konopleva, Marina
Jabbour, Elias
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (12): : 897 - 901
[39] Safety and Efficacy of Blinatumomab in Combination with a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-Positive Leukemia
Assi, Rita
Kantarjian, Hagop
Short, Nicholas J.
Daver, Naval
Takahashi, Koichi
Garcia-Manero, Guillermo
DiNardo, Courtney
Khouri, Rita
Burger, Jan
Jain, Nitin
Wierda, William
Chamoun, Salim
Konopleva, Marina
Jabbour, Elias
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S265 - S265
[40] Safety and Efficacy of Blinatumomab in Combination with a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-Positive Leukemia
Assi, Rita
Kantarjian, Hagop M.
Short, Nicholas J.
Daver, Naval
Takahashi, Koichi
Garcia-Manero, Guillermo
DiNardo, Courtney D.
Khouri, Maria
Burger, Jan A.
Cortes, Jorge E.
Jain, Nitin
Wierda, William G.
Chamoun, Salim
Konopleva, Marina
Jabbour, Elias J.
BLOOD, 2017, 130

← 1 2 3 4 5 →